SCHEMBL24439686

SCHEMBL24439686

O=C(Cc1ccc2c(c1)[nH]c1ccccc12)NCc1ccc(F)c(F)c1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.56
ALDH1A1 P00352 4/20 0.56
HSD17B10 Q99714 3/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
P2RX7 Q99572 1/20 0.47
RAB9A P51151 2/20 0.46
KIF11 P52732 1/20 0.46
LMNA P02545 2/20 0.46
HPGD P15428 2/20 0.46
SRC P12931 2/20 0.45
EGFR P00533 1/20 0.44
ERCC1 P07992 1/20 0.44
ERCC4 Q92889 1/20 0.44
NLRP3 Q96P20 1/20 0.44
IMPDH2 P12268 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29605748 1.00 KDM4E (0.56) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL29606907 0.90 KDM4E (0.53) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL29606308 0.90 KDM4E (0.53) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL29605815 0.88 KDM4E (0.62) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL24439890 0.88 KDM4E (0.62) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL24439882 0.87 KDM4E (0.64) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL29606360 0.87 KDM4E (0.64) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL24439700 0.86 ALDH1A1 (0.58) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL29605177 0.86 ALDH1A1 (0.58) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL24439911 0.86 KDM4E (0.53) KDM4EALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022103149-A1 NOVEL CARBAZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING SAME AS ACTIVE INGREDIENT 주식회사 큐라클 2022-05-19 WO disclosed